Will Cannabis Seeds Be Banned?
The redefinition of hemp under federal law, set to take place Nov. 12, signals the loss of Farm Bill protections for many hemp-derived THC products across the nation: mild beverages as well as THCA flower and delta-8 THC edibles, vapes and other products available at gas stops and smoke shops.
But the hemp ban also creates a significant complication for the legitimate cannabis industry. Seeds from cannabis varieties that generate flower with greater than 0.3% THC are no longer legal to ship out of state.
Although seed purchases will probably continue in authorized states, the changes threaten to shutter some seed banks and genetics businesses, observers note, while creating supply-chain problems for cannabis growers and retailers.
“If this language goes forward, we will require pop-up stores to sell seeds in every state where it’s permitted,” Campanella said. “Which is why we’re also offering clones and tissue cultivation, because that’s not included in the bill.”
When are cannabis seeds and clones illegal to ship across state lines?
The updated regulations classify seeds depending on the THC potential of the parent plant. Genetic material such as seeds and clones are made illegal if the end product crosses the threshold.
For the moment, seeds are still shipping under the 2018 Farm Bill’s current quo. But the clock is ticking for businesses like Brothers Grimm and for cannabis growers who fear supply chain interruptions if out-of-state availability to genetics is banned.
Most of the cannabis industry remains mostly unaware of the impending shutdown of the interstate genetics market, said Ryan Power, cofounder of Sebastopol, California-based company Atlas Seed.
Without government intervention in the form of a carve-out for seeds or an overall moratorium, many seed suppliers will simply be shuttered come November, he added.
“We are functioning legally currently, but if that changes, it will disrupt the legitimate licensed industry in every state,” said Power, whose clientele includes seed banks as well as licensed business cultivators.
“Customers are going to lose choice, and it will be a significant shutdown for many people.”
What are cannabis seed suppliers doing to stay legal after the federal hemp ban?
Sagui Silber has already recalibrated Silberhaze Genetics, https://nativesusa.com/; nativesusa.com, his Ohio genetics business, because of state Senate Bill 56, which tightened cannabis supervision in that state while also restricting hemp-derived THC items to licensed cannabis retailers.
Formerly a seed supplier, Silberhaze is now focused on the marketing, preservation and IP safeguarding of premium plant genetics.
That’s because seed businesses hoping to remain compliant in this new environment must have solid documentation, he said.
“You have to demonstrate where this material comes from, so it’s very important to have documentation, even to the extent where you have cultivator names,” Silber said.
“Smaller businesses will have to operate with improved records and a better chain of possession,” he added. “We need that documentation too, because we don’t want to be dealing with shady sources.”
To avoid seizures and other legal consequences, seed business owners must “get their affairs in order” before the updated regulations take effect, Silber said.
“Review all your materials immediately, and categorize what you can,” Silber said. “Take inventory, document your heritage, preserve cultivator records, and organize any cannabinoid or terpene data you currently have. If regulations change, you’ll be in a much better position to comprehend what may be affected and make informed decisions.”
Does government marijuana rescheduling impact cannabis genetics?
Silber believes U.S. Drug Enforcement Administration registration may be required for companies engaged in research.
But for now, seed companies can’t register with the DEA like state-licensed medical cannabis operators can. Such a pathway is not available to seed suppliers, nurseries or genetics businesses, said Jim Ickes, an attorney and partner with Frantz Ward’s cannabis practice group in Cleveland.
“Genetics activity may be occurring inside broader state-licensed medical marijuana operations, as some states permit dispensaries or registered therapeutic operators to sell seeds, clones or personal growing materials,” he said.
“But that is distinct from the DEA creating a freestanding seed bank registration category.”
Some genetics companies are currently changing operational practices to conform with the updated law. According to Ickes, they must answer questions including:
- Which of our lines produce plants over 0.3% total THC?
- Which seeds survive as hemp after Nov. 12, 2026, and which don’t?
- What does our inventory look like once we sort it against the viable-seed exclusion?
Ickes also recognizes confusion from clients who believed federal rescheduling of therapeutic marijuana would clarify their situation with financial institutions. However, the latest regulatory wording has shifted those conversations past the fundamentals of classification, he said.
“Financial institutions ask whether this particular revenue source is lawful, whether it connects to state-licensed activity, or whether there’s cross-state risk,” said Ickes.
“After November, a seed bank selling high-THC genetics can’t address the initial question with the hemp classification. It has to refer to a lawful state cannabis channel instead. Seed banks dealing in genuine industrial-hemp seed maintain the cleaner story.”
What’s the future of cannabis genetics?
Campanella is a member of a emerging coalition of fellow breeders, farmers and researchers that’s arguing seeds are better defined as agricultural inputs than regulated substances. To that end, seeds should be managed by the U.S. Department of Agriculture, allowing the DEA to concentrate its enforcement efforts elsewhere.
“How do you control something based on what it could become one day?” said Campanella. “Our preference is to have that language removed, or get seeds regulated by the USDA as a hemp product.”
But in the interim, Campanella is restructuring Brothers Grimm to function outside the scope of shifting federal oversight. The business plans to maintain its Colorado seed operation while positioning its Oklahoma tissue culture facility as a safeguard against government prohibition of cannabis seeds.
As she noted: “If things develop in a way where we can’t focus on interstate shipping, we’ll have other resources to satisfy people’s requirements without putting ourselves in trouble.”